![Benjamin Weinberg: Efficacy of Zenocutuzumab in NRG1 Fusion-Positive Cancer](https://oncodaily.com/pub/uploads/2025/02/Снимок-экрана-2025-02-06-175446.jpg)
Benjamin Weinberg/LinkedIn
Feb 7, 2025, 12:32
Benjamin Weinberg: Efficacy of Zenocutuzumab in NRG1 Fusion-Positive Cancer
Benjamin Weinberg, Associate Professor Of Medicine at Georgetown Lombardi Comprehensive Cancer Center, shared an article he and colleagues authored on X:
“Paper is out!!! FDA approved for NRG1 Fusion+ Non-Small Cell Lung Cancer and Pancreatic Cancer
Efficacy of Zenocutuzumab in NRG1 Fusion–Positive Cancer.”
Efficacy of Zenocutuzumab in NRG1 Fusion–Positive Cancer
Authors: Alison M. Schram et al.
Alexander Drilon
Alison M. Schram
Andrew K. Joe
Antoine Hollebecque
Benjamin A. Weinberg
cancer
Christoph Springfeld
Cindy Neuzillet
Dong-Wan Kim
Eileen M. O'Reilly
Emiliano Calvo
Ernesto Wasserman
Frans Opdam
Grainne M. O'Kane
James M. Cleary
Jim Ford
Joon Oh Park
Jordi Rodon
Kazumi Nishino
Kim A. Reiss
Koichi Goto
Kumiko Umemoto
Lokesh Jain
Michael Duruisseaux
Misako Nagasaka
OncoDaily
Oncology
Sai-Hong Ignatius Ou
Shekeab Jauhari
Shola Adeyemi
Stephen V Liu
Sun Young Rha
Tanios Bekaii-Saab
Teresa Macarulla
Viktoriya Stalbovskaya
zenocutuzumab
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 7, 2025, 17:31
Feb 7, 2025, 17:21